Fig. 5From: Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivityRBM3 related genes. Volcano plot illustrating differentially expressed genes based on RNA-sequencing of siRBM3-treated and non-targeting siRNA control T24 cells, showing 197 and 145 significantly up- and downregulated genes, respectively, with fold change of ≤1.5/≥ 1.5, and FDR < 0.01 (out of total 13,627 genes detected). NS, Not significant. FC, fold changeBack to article page